We have learned that the data being generated fr

We have learned that the data being generated from the Swiss and Israeli MAPS-sponsored studies will be accepted by the US FDA. Although these protocols do not need to be approved by the FDA to be conducted …

The Second Prospective Study of Ecstasy Users

The Second Prospective Study of Ecstasy Users: No Support for Changes in Brain Activity, Associative Memory or Selective Attention. By Ilsa Jerome, Ph.D. Ilsa Jerome May 2007 New research just published …

An encouraging advancement is that we may be clo

An encouraging advancement is that we may be close to enrolling the final five subjects needed to complete Dr. Mithoefer’s study. We’ve focused more attention on recruitment with ads on various …

After several years of effort, three rejections,

After several years of effort, three rejections, and an appeal, the Institutional Review Board (IRB) for Dr. Michael Mithoefer’s flagship MAPS-sponsored US MDMA/PTSD study approved an amendment to …

MAPS has committed $5,300 to Dr. Franz Vollenwei

MAPS has committed $5,300 to Dr. Franz Vollenweider at the Psychiatric University Hospital in Zurich to co-sponsor a secondary study that will gather data for physiological assessments of subjects in Dr. …

MAPS has donated $3000 to Pal-Orjan Johansen and

MAPS has donated $3000 to Pal-Orjan Johansen and Terri Krebs for a project that will seek to use the internet to search for reports of people with Asperger’s (a form of high-functioning autism) who …

From January 3-6, 2007, MAPS’ clinical research

From January 3-6, 2007, MAPS’ clinical research team (Amy Emerson, Valerie Mojeiko, and Josh Sonstroem) was in Charleston, SC, conducting a monitoring inspection of Dr. Michael Mithoefer’s …

News Coverage of Dutch Prospective Ecstasy User Studies

In response to the sensationalistic and inaccurate recent news coverage of prospective Ecstasy user studies by Dutch researcher Dr. Maartje M. de Win, MAPS President Rick Doblin, Ph.D. wrote this open …

PDF File

While in Thailand to testify in a medical MDMA trial, MAPS President Rick Doblin took the opportunity to do an interview with The Nation, Thailand’s largest English-language daily newspaper. In the …

The MAPS clinical research monitoring team arriv

The MAPS clinical research monitoring team arrives in Israel today for the Site Initiation visit for the MAPS-sponsored MDMA/PTSD pilot study at Beer Yakhov Mental Health Center in Tel Aviv, Israel, under …

PDF File

VG, one of the largest Norwegian newspapers, published a very positive piece on MDMA psychotherapy research that includes interviews with Charles Grob, M.D., and Pål-Ørjan Johansen, Ph.D. …

PDF Article

An excellent roundtable discussion about psychedelics and Judaism was published in Jewish Currents, published by the Association for Promotion of Jewish Secularism, Inc. The article is entitled, “Just …